Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 33.75% is in line with its 5-year average of 34.16%, near the low end of its 5-year range (32.34%–39.80%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.22% above its 12-month average of 33.34%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
33.75%
GROSS MARGIN AVG TTM
33.34%
GROSS MARGIN AVG 3Y
33.06%
GROSS MARGIN AVG 5Y
33.21%
GROSS MARGIN AVG 10Y
35.49%
GROSS MARGIN AVG 15Y
36.79%
GROSS MARGIN AVG 20Y
37.88%
CURRENT VS TTM AVG
+1.22%
CURRENT VS 3Y AVG
+2.08%
CURRENT VS 5Y AVG
+1.62%
CURRENT VS 10Y AVG
-4.89%
CURRENT VS 15Y AVG
-8.26%
CURRENT VS 20Y AVG
-10.90%
SECTOR MEDIAN · HEALTHCARE
58.69%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-42.50%
vs the sector median at left
Quest Diagnostics Incorporated
Market Cap
$26.18B
Gross Margin
33.75%
TTM Avg
33.34%
3Y Avg
33.06%
5Y Avg
33.21%
Market Cap
$26.19B
Gross Margin
27.85%
TTM Avg
27.30%
3Y Avg
28.39%
5Y Avg
31.16%
Market Cap
$25.07B
Gross Margin
36.77%
TTM Avg
35.27%
3Y Avg
37.10%
5Y Avg
37.60%
Market Cap
$24.80B
Gross Margin
92.62%
TTM Avg
92.70%
3Y Avg
93.10%
5Y Avg
93.74%
Market Cap
$29.04B
Gross Margin
59.30%
TTM Avg
57.84%
3Y Avg
57.54%
5Y Avg
57.23%
Market Cap
$29.25B
Gross Margin
79.72%
TTM Avg
83.69%
3Y Avg
83.53%
5Y Avg
83.62%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quest Diagnostics Incorporated (DGX) | $26.18B | 33.75% | 33.34% | 33.06% | 33.21% |
| Labcorp Holdings Inc. (LH)vs › | $26.19B | 27.85% | 27.30% | 28.39% | 31.16% |
| West Pharmaceutical Services, Inc. (WST)vs › | $25.07B | 36.77% | 35.27% | 37.10% | 37.60% |
| Incyte Corporation (INCY)vs › | $24.80B | 92.62% | 92.70% | 93.10% | 93.74% |
| Medline Inc. (MDLN)vs › | $28.48B | 24.04% | 25.55% | 23.71% | 23.71% |
| Moderna, Inc. (MRNA)vs › | $23.70B | 55.35% | 54.80% | 53.09% | 65.45% |
| BioNTech SE (BNTX)vs › | $23.50B | 73.26% | 78.98% | 81.24% | 82.89% |
| Mettler-Toledo International Inc. (MTD)vs › | $29.04B | 59.30% | 57.84% | 57.54% | 57.23% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $29.25B | 79.72% | 83.69% | 83.53% | 83.62% |
| STERIS plc (STE)vs › | $23.02B | 43.97% | 44.13% | 43.77% | 43.82% |
Gross Margin
33.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 33.75% |
| 2026-03-31 | 32.54% |
| 2025-12-31 | 32.57% |
| 2025-09-30 | 33.70% |
| 2025-06-30 | 34.15% |
| 2025-03-31 | 32.54% |
| 2024-12-31 | 32.74% |
| 2024-09-30 | 32.60% |
| 2024-06-30 | 33.54% |
| 2024-03-31 | 32.59% |
| 2023-12-31 | 32.34% |
| 2023-09-30 | 32.85% |
| 2023-06-30 | 33.88% |
| 2023-03-31 | 33.08% |
| 2022-12-31 | 32.49% |
| 2022-09-30 | 34.92% |
| 2022-06-30 | 34.33% |
| 2022-03-31 | 36.96% |
| 2021-12-31 | 37.39% |
| 2021-09-30 | 39.80% |
| 2021-06-30 | 38.63% |
| 2021-03-31 | 40.22% |
| 2020-12-31 | 42.27% |
| 2020-09-30 | 43.29% |
| 2020-06-30 | 33.17% |
| 2020-03-31 | 30.30% |
| 2019-12-31 | 34.37% |
| 2019-09-30 | 35.38% |
| 2019-06-30 | 35.23% |
| 2019-03-31 | 34.21% |
| 2018-12-31 | 32.84% |
| 2018-09-30 | 35.31% |
| 2018-06-30 | 35.23% |
| 2018-03-31 | 34.93% |
| 2017-12-31 | 38.33% |
| 2017-09-30 | 38.37% |
| 2017-06-30 | 39.78% |
| 2017-03-31 | 38.65% |
| 2016-12-31 | 37.67% |
| 2016-09-30 | 38.62% |
| 2016-06-30 | 39.40% |
| 2016-03-31 | 38.59% |
| 2015-12-31 | 37.80% |
| 2015-09-30 | 38.19% |
| 2015-06-30 | 38.60% |
| 2015-03-31 | 36.76% |
| 2014-12-31 | 37.12% |
| 2014-09-30 | 38.13% |
| 2014-06-30 | 38.28% |
| 2014-03-31 | 36.94% |
| 2013-12-31 | 40.15% |
| 2013-09-30 | 39.09% |
| 2013-06-30 | 39.76% |
| 2013-03-31 | 38.89% |
| 2012-12-31 | 39.53% |
| 2012-09-30 | 41.14% |
| 2012-06-30 | 41.76% |
| 2012-03-31 | 42.34% |
| 2011-12-31 | 42.67% |
| 2011-09-30 | 41.43% |
| 2011-06-30 | 41.97% |
| 2011-03-31 | 39.78% |
| 2010-12-31 | 40.77% |
| 2010-09-30 | 41.47% |
| 2010-06-30 | 42.45% |
| 2010-03-31 | 40.94% |
| 2009-12-31 | 42.10% |
| 2009-09-30 | 42.15% |
| 2009-06-30 | 42.15% |
| 2009-03-31 | 41.73% |
| 2008-12-31 | 42.18% |
| 2008-09-30 | 41.25% |
| 2008-06-30 | 41.05% |
| 2008-03-31 | 40.68% |
| 2007-12-31 | 41.10% |
| 2007-09-30 | 41.90% |
| 2007-06-30 | 40.97% |
| 2007-03-31 | 38.95% |
| 2006-12-31 | 40.66% |
| 2006-09-30 | 41.02% |
| 2006-06-30 | 40.89% |
| 2006-03-31 | 40.66% |
| 2005-12-31 | 39.26% |
| 2005-09-30 | 41.17% |
| 2005-06-30 | 42.02% |
| 2005-03-31 | 40.88% |
| 2004-12-31 | 40.98% |
| 2004-09-30 | 41.98% |
| 2004-06-30 | 41.57% |
| 2004-03-31 | 41.29% |
| 2003-12-31 | 41.34% |
| 2003-09-30 | 41.76% |
| 2003-06-30 | 42.36% |
| 2003-03-31 | 40.69% |
| 2002-12-31 | 40.09% |
| 2002-09-30 | 40.96% |
